当前位置：
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The identification of a CD47-blocking "hotspot" and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination.
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2020-03-06 , DOI: 10.1038/s41392-020-0121-2 Rui Shi 1, 2 , Yan Chai 3 , Xiaomin Duan 1, 2 , Xiaoshan Bi 1, 4 , Qingrui Huang 1 , Qihui Wang 1 , Shuguang Tan 3 , George F Gao 2, 3 , Jianhua Zhu 5 , Jinghua Yan 1, 2, 3, 4
中文翻译：
CD47 阻断“热点”的鉴定和具有有限血凝作用的 CD47/PD-L1 双特异性抗体的设计。
更新日期：2020-03-06
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2020-03-06 , DOI: 10.1038/s41392-020-0121-2 Rui Shi 1, 2 , Yan Chai 3 , Xiaomin Duan 1, 2 , Xiaoshan Bi 1, 4 , Qingrui Huang 1 , Qihui Wang 1 , Shuguang Tan 3 , George F Gao 2, 3 , Jianhua Zhu 5 , Jinghua Yan 1, 2, 3, 4
Affiliation
|
中文翻译：
CD47 阻断“热点”的鉴定和具有有限血凝作用的 CD47/PD-L1 双特异性抗体的设计。
京公网安备 11010802027423号